Adult Primary Care (APC) 2023: Symptom-based Integrated Approach to the Adult in Primary Care

Objectives

Adult Primary Care is a comprehensive, patient-centred clinical decision-support tool for primary-care practitioners caring for adults aged 18 years and older. It applies approved South African National Department of Health policies and guidelines to support respectful communication, individual choice, continuity of care, follow-up and links with community resources.[1]

• Provide integrated assessment and management of general health concerns, symptoms, emergencies, chronic conditions and preventive care through a structured consultation process.[2]
• Cover a broad primary-care scope, including tuberculosis, human immunodeficiency virus, coronavirus disease 2019, respiratory disease, cardiovascular disease, diabetes, mental health, epilepsy, musculoskeletal conditions, sexual and reproductive health, maternal care, skin conditions, injuries, palliative care and Long COVID.[1][3]
• Promote prevention through screening, vaccination, lifestyle support, safer sex, smoking cessation, healthy eating, physical activity, alcohol and drug harm reduction, and cardiovascular-risk management.[4][5][6]
• Strengthen safe prescribing, medicine adherence, patient understanding, adverse-reaction reporting and appropriate referral when clinical risks exceed primary-care capacity.[7][8]
• Support long-term care for HIV, tuberculosis, diabetes, hypertension, chronic respiratory disease, chronic pain, mental illness and other continuing conditions through regular assessment, treatment adjustment and self-management support.[9][10][11][12]

The guidance is aligned with national clinical protocols and treatment guidance, including the Standard Treatment Guidelines and Essential Medicines List. It is intended as a practical, integrated tool rather than a standalone disease-control strategy; the supplied material does not specify a separate overarching policy mission, budget or formal programme targets.[2][13]

Implementation

Delivery is consultation-based, combining urgent triage, symptom assessment, chronic-condition review, preventive interventions, patient counselling, treatment, safety-netting and referral. It uses pathways for stable patients, symptomatic presentations and known chronic conditions, including urgent-attention pathways and the Assess, Advise and Treat framework for routine chronic care.[2]

• Integrate Adult Primary Care within Integrated Clinical Services Management and the Ideal Clinic Realisation and Maintenance initiative, complemented by the Health for All health-promotion tool.[1]
• Use national treatment guidelines, approved formularies and clinical protocols to guide diagnosis, prescribing, monitoring, escalation and referral.[2][13]
• Train practitioners through simulated case scenarios and make the electronic tool available through the Knowledge Hub.[1]
• Revise content in response to updated national guidance, emerging evidence, National Department of Health circulars and end-user feedback.[14]
• Coordinate development and refinement through the Knowledge Translation Unit with the National Department of Health, National Essential Medicines List Committee, Clinical Programmes, clinicians, policy makers and end-users.[2]

Operationally, practitioners assess clinical risk and vital signs, provide immediate treatment for emergencies, arrange same-day or urgent referral where required, and use scheduled reviews, investigations and condition-specific thresholds to guide continuing care. Examples include routine monitoring for treatment adherence and adverse effects in tuberculosis and HIV care, viral-load and laboratory follow-up, blood-pressure and glucose monitoring, chronic respiratory assessment, and clinical screening during pregnancy and postnatal care.[15][16][17][11][18][19]

• Support adherence through patient-centred counselling, treatment planning, reminders, community health workers, support groups, treatment partners and repeat prescription collection points for eligible stable patients.[20][10][8]
• Use electronic and clinical records, including TIER.net for tuberculosis care and the electronic drug-resistant tuberculosis register for rifampicin-resistant tuberculosis, to document patient management and outcomes.[21][22]
• Report suspected medicine reactions through recognised adverse-drug-reaction reporting channels, including the MedSafety App and South African Health Products Regulatory Authority routes.[7][23]
• Maintain infection prevention through ventilation, reduced overcrowding, respiratory triage, safe sharps disposal, protective equipment and an appointed facility infection control officer.[24][25]
• Link patients with specialist, hospital, rehabilitation, social-work, mental-health, community, spiritual and palliative-care services according to clinical and psychosocial needs.[26][27][28]

Monitoring is primarily clinical and condition-specific, relying on scheduled reviews, laboratory tests, documented treatment outcomes, patient records, adverse-event reporting and referral triggers. The supplied material does not specify a consolidated programme-level evaluation framework, performance dashboard, financing mechanism, budget allocation or economic analysis.[16][29][30]

Monitoring & Evaluation

Monitoring is principally embedded in routine clinical care rather than a unified programme-level evaluation system. Across the supplied guidance, clinicians are directed to assess symptoms, treatment adherence, adverse effects, vital signs, laboratory results, functional status and referral needs at defined visits; formal indicators, reporting schedules, audit arrangements and system-wide accountability mechanisms are generally not specified.[1][9][29][25]

• Monitor preventive and general primary-care activities through scheduled screening for body mass index, blood pressure, cardiovascular and diabetes risk, HIV, cervical disease, breast abnormalities and functional or cognitive change in older people.[4][31]
• Record routine observations, including weight, blood pressure, pulse and temperature, with respiratory rate for respiratory symptoms and glucose testing for unwell patients with known diabetes; escalate abnormal findings according to clinical thresholds.[15][32]
• Report suspected medicine reactions through the MedSafety App, World Health Organization-Uppsala Monitoring Centre reporting website or adverse drug reaction forms submitted to the South African Health Products Regulatory Authority.[7][15][33][23]
• Notify adverse events following immunisation electronically or through the National Department of Health Case Reporting Form, and inform the relevant sub-district or district office and provincial Expanded Programme on Immunisation manager within 24 hours.[34]
• Use clinical follow-up, safety-netting and referral triggers extensively, including defined reassessment intervals for wounds, burns, chronic pain, respiratory disease, diabetes, hypertension, mental health conditions, pregnancy and postnatal care.[35][36][37][11][12][38][39][40]

Tuberculosis and HIV sections contain the most developed documentation and outcome-monitoring processes. Tuberculosis care requires assessment of symptoms, adherence, side effects, weight, body mass index, glucose, HIV status and relevant results at diagnosis and every visit, alongside completion of patient records and capture on TIER.net.[9][21]Drug-sensitive tuberculosis monitoring includes smear or culture assessment at diagnosis and monthly, drug-susceptibility testing when culture remains positive, treatment-outcome recording at completion and annual tuberculosis screening for two years after treatment.[41][42][43][44]

• Document tuberculosis preventive treatment outcomes as completed, stopped, lost to follow-up or died, and monitor monthly for tuberculosis symptoms, adverse effects and peripheral neuropathy.[16]
• Update the electronic drug-resistant tuberculosis register with current sputum results at every visit, monitor attendance and adverse effects, and use adverse-drug-reaction reporting to support accountability.[22][45]
• Monitor rifampicin-resistant and pre-extensively drug-resistant tuberculosis through monthly sputum microscopy and culture after the first four weeks, drug-susceptibility testing, electrocardiography, hearing and vision checks, blood counts, liver and renal function, electrolytes, thyroid function, HIV viral load and CD4 count.[29][46][47]
• Record treatment outcomes, including cure, success, failure, loss to follow-up, transfer, death and not evaluated, using culture conversion, consecutive negative cultures, treatment duration and clinical status.[48]

HIV prevention and treatment guidance specifies repeated clinical and laboratory monitoring. Pre-exposure prophylaxis requires HIV testing before initiation, after one month and then every three months, with renal and hepatitis B assessment and visit recording on the PrEP Clinical Form.[49][50][51][52]Post-exposure prophylaxis follow-up occurs within three days, at four weeks and at four months, with repeat HIV testing and infection-specific follow-up tests.[53][54][55]HIV treatment monitoring includes staged viral-load testing, CD4 testing where indicated, medicine-specific safety tests and annual tuberculosis testing alongside viral-load monitoring.[17][56][57][58]

Maternal, newborn and infectious-disease care also incorporates defined surveillance-like actions. Acute hepatitis A cases are to be notified, while suspected cholera cases are to be notified and supported by stool or rectal-swab testing.[59][60][61]Antenatal care uses serial symphysis-fundal height, blood pressure, urine, glucose, haemoglobin, Coombs and syphilis testing, while postnatal care specifies contacts at six hours, six days and six weeks.[39][62][63][19][40]Newborn follow-up includes hepatitis B testing at nine months and repeated HIV testing at defined points during infancy and breastfeeding.[64][65]

Accountability is mainly clinical and operational: facility infection-control officers coordinate and monitor infection-control policies; clinicians document agreed patient goals, treatment decisions, referral information and selected statutory mental-health forms; and guideline refinement incorporates end-user feedback.[2][66][25][67]The supplied material does not establish a consolidated national performance dashboard, routine audit cycle, evaluation design, target set or cross-programme reporting framework.[13][14][29][68]

Costing & Financing

The supplied guidance provides extensive clinical resource requirements but does not specify a costing methodology, programme budget, financing source, allocation, funding gap, resource-mobilisation plan or economic assumption.[1][9][27][68]

• Identify clinical inputs including medicines, diagnostic tests, oxygen, intravenous fluids, emergency equipment, laboratory services, referrals, specialist input, community health-worker support and information systems, without associated prices or financial allocations.[69][70][71][72][29]
• Note resource-related implementation considerations for testing capacity, facility infection prevention, respiratory protection, ventilation, specimen transport and cold-chain requirements, without budgetary quantification.[73][74][24][25]
• Recognise that Long COVID guidance directs unemployed patients to apply to the South African Social Security Agency for the COVID-19 Social Relief of Distress Grant and recommends social-work referral for financial concerns, but gives no grant value or funding details.[27][75]
• Recognise that infant-feeding guidance identifies long-term affordability, access to clean boiled water and acceptability as considerations for exclusive formula feeding, but provides no monetary estimates.[76]

No explicit machine-readable monetary cost, budget or funding-allocation value is available in the supplied summaries.[1][68]